Want to join the conversation?
Gregg Gilbert of Deutsche Bank asks for an update on Inflectra launch. Pfizer Essential Health President John Young replied that $PFE is moving ahead with launch preparations and the launch timing will be impacted by the upcoming court decision.
Biodefense therapeutics firm $PIP announced an all-stock merger with biotech Altimmune. The respective boards of the two companies unanimously approved the merger.
$YHOO is reporting today after market close. Nobody cares about this stock.